Create an HTML page using whatever layout and sizing you like. Link to your own stylesheets for consistency with your main website. Then place the word [ minisite ] where you want our MiniSite to appear. Our system automatically inserts the latest content and serves it to your readers.
Navigation
When your navigation changes, you can log into our admin panel and upload a new template. Or, just use an iframe to share code from your main website. We don't stand between you and your regular web updates.
In addition to your standard site navigation, MiniSites are a great place to link to existing revenue drivers. You can create any connections you like between different areas of your site. MiniSites can offer gateways to:
Scientists have identified a gene that predicts post-surgical survival for brain-metastatic breast cancer patients
By Perry Gattegno CTW Features
Researchers may have unlocked a door to the discovery of how breast cancer metastasizes to the brain, leading to optimism about future treatments of the disease.
Dr. Diane Palmieri of the National Cancer Institute, Rockville, Md., says the gene, hexokinase 2, was more highly expressed in brain metastasis in patients with breast cancer than in primary breast tumors. The study containing this discovery was published in Molecular Cancer Research. Hexokinase 2 plays a starring role in glucose metabolism, which provides fodder for tumors to grow. It also effects apoptosis, the cell survival process.
"Potential therapies would need to turn off this gene and thus starve the tumor of its growth potential," Dr. Palmieri says.
Researchers analyzed both primary tumors as well as brain metastases, finding higher levels of hexokinase 2 in the metastatic tumors compared to unrelated primary tumors. The median survival for patients with high levels of hexokinase 2 expression in their brain metastasis was 9.6 months, but patients survived a median of 17.5 months for those with lower expression. This finding is a giant step in the search for a breast cancer cure, Dr. Brunhilde Felding-Habermann says.
"Improvements in breast cancer therapy have made prognoses like brain metastasis a growing problem," says Dr. Felding-Habermann, an associate professor at the Scripps Research Institute, La Jolla, Calif., "and this research points to a potential target for future therapies."
At this time, there is no local version of bodyandmore365.com available. You may continue with the national version now, or try another zip code.
Match found
A local version of bodyandmore365.com is available from {name} in {city}, {state}. We will redirect you to that site now.
Matches found
Local versions of bodyandmore365.com are available from the following sources. Please select the version you'd like to view:
{clients}
Advertisements
You can use the space around the MiniSite content to create multiple ad and sponsorship positions that you can customize to your market. In fact, you can create a premium sponsorship opportunity by inserting ads or custom navigation inside the MiniSite area using a special feature in our system.
If you use JavaScript tags for ad serving or site tracking, you can add them to your template, and manage your MiniSite pages with the same tools you use to manage the rest of your site.